 |
| Myopia And Presbyopia Eye Drops Market |
Myopia and presbyopia are common vision conditions affecting people worldwide. Myopia or nearsightedness is a condition where the eyes have trouble focusing on distant objects, while presbyopia is difficulty focusing on nearby objects. Eye drops are used to temporarily relieve blurred vision caused by these conditions. The advantages of using eye drops include immediate relief, ease of administration, and affordable cost of treatment. Myopia and presbyopia eye drops help enhance vision clarity without requiring spectacles or contact lenses. The growing geriatric population worldwide prone to presbyopia and increasing prevalence of myopia among children and young adults are major factors driving demand.
The global myopia and presbyopia eye drops market is estimated to be valued at US$ 184.45 billion in 2024 and is
expected to exhibit a CAGR of 8.2%
over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the myopia and presbyopia eye drops are Johnson
Controls, ATLASBX Co. Ltd., Exide Technologies, East Penn Manufacturing Co,
Crown Battery Manufacturing Company, C&D Technologies INC., GS Yuasa
Company, Leoch International Technology Ltd, Chaowei Power Holdings Limited,
and Camel Group Co. Ltd., Hoppecke Batterien GmbH & Co. KG.
The key opportunities in the market include rising disposable incomes in
developing countries enabling better access to treatments and growing awareness
regarding vision care. Technological advancements like digital Myopia
And Presbyopia Eye Drops Market Size and apps are also boosting the market.
Market drivers: The primary driver behind the growth of the myopia and
presbyopia eye drops market is the rapidly growing geriatric population worldwide
who are more prone to presbyopia. According to estimates, over 1.5 billion
people will be aged 65 years and above by 2050. Other major drivers include
increasing prevalence of myopia mainly due to excessive screen time among young
people.
Current challenges in Myopia And Presbyopia Eye Drops Market
The myopia and presbyopia eye drops market is facing many challenges currently.
One of the major challenges is growing resistance to existing drugs. As more
eye drops are used, the bacterial strains are developing resistance to them,
making the drugs less effective over time. Secondly, the side effects of
existing drugs like burning sensation, redness, itching are causing low
treatment compliance among patients.
Newer drugs are needed that are free
of such side effects. Thirdly, rising healthcare costs are putting pressure on
pharmaceutical companies to develop low cost Myopia
And Presbyopia Eye Drops Market Size And Trends Overall, investments in R&D for novel
formulations and drug delivery mechanisms are needed to address the current
treatment challenges in this market.
SWOT Analysis
Strength: Growing prevalence of myopia and presbyopia worldwide is driving the
market growth. Availability of various prescription and OTC eye drops offers
treatment options.
Weakness: Side effects of existing drugs like burning sensation, redness lowers
patient compliance. High R&D costs involved in development of new drug
molecules.
Opportunity: Untapped growth potential in developing countries presents market
expansion opportunities. Novel drug delivery technologies can help reduce side
effects and costs.
Threats: Increasing resistance to existing drugs threatens long term
sustainability. Patents expiry of blockbuster drugs allows generic competition.
Geographical regions of concentration
North America currently holds the largest share in the myopia and presbyopia
eye drops market, both in terms of value and volume. This is attributed to the
rising prevalence of myopia in countries like United States and availability of
supportive healthcare infrastructure. Europe accounts for the second largest
regional market led by countries like Germany, United Kingdom and France.
Fastest growing region
Asia Pacific region is poised to be the fastest growing regional market for
myopia and presbyopia eye drops during the forecast period. The key factors
driving the growth include rising disposable incomes, growing awareness about
eye care and availability of generic drugs at low costs. China and India are
emerging as lucrative markets, given the large patient pool suffering from
refractive errors in these countries.
About
Author:
Money Singh is a seasoned content writer with over
four years of experience in the market research sector. Her expertise spans
various industries, including food and beverages, biotechnology, chemical and
materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
0 Comments